Log in to search using one of your social media accounts:

 

Screening for cervical abnormalities in women offered HPV vaccination

(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

Excerpted fromPrecision Medicine and the Reinvention of Human DiseaseDespite having the most advanced healthcare technology on the planet, life expectancy in the United States is not particularly high. Citizens from most of the European countries and the highly industrialized Asian countries enjoy longer life expectancies than the United States. According to the World Health Organization, the United States ranks 31st among nations, trailing behind Greece, Chile, and Costa Rica, and barely edging out Cuba [42]. Similar rankings are reported by the US Central Intelligence Agency [43]. These findings lead us to infer that acc...
Source: Specified Life - Category: Information Technology Tags: cancer cancer vaccines precision medicine prevention public health Source Type: blogs
The national cervical screening programme, CervicalCheck, commenced in Ireland in 2008. Free cervical smear tests are offered to over 1.2 million women aged 25–60 every 3 (aged 25–44) and 5 (aged 45–60) years. The purpose of this paper is to highlight the achievements and document the experience of the first 6 years of a new cervical screening programme. Data were extracted from the programme screening register and colposcopy management systems. SAS, version 9.4 was used for statistical analysis. Over 1.98 million smear tests were performed in over 1 million women during the first 6 years of the programme...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Research Papers: Gynecological Cancer Source Type: research
Women who have had the human papillomavirus (HPV) jab may only need 3 smear tests for cervical cancer in their lifetime, a study suggests.WebMD Health News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
The tumors of the female genital tract represent a huge health problem in Europe, Endometrial Cancer, EC, with 6.1% of cases estimated in 2012 [1] is the most common, followed by Epithelial Ovarian Cancer, EOC, and Cervical Cancer, CC; those malignancies have distinct biology and molecular features and differ from each other based on clinical behavior, nevertheless all them are associated with high mortality. Important goals have been achieved in CC prevention and treatment: the worldwide spreading of the Papanicolaou test, PAP test, has dramatically increased the rate of diagnosis for precancerous conditions/early stage t...
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Tumour Review Source Type: research
Authors: Dalgo Aguilar P, Loján González C, Córdova Rodríguez A, Acurio Páez K, Arévalo AP, Bobokova J Abstract Human papillomavirus (HPV) is the primary infectious agent for the development of cervical cancer, although the presence of the virus alone is insufficient for viral development and proliferation; this can be attributed to the increase in potential oncogenic risk, along with other risk factors. In the present investigation, the prevalence of high-risk HPV was determined from samples of premalignant or malignant cervical cytology in women from the southern region o...
Source: Infectious Diseases in Obstetrics and Gynecology - Category: OBGYN Tags: Infect Dis Obstet Gynecol Source Type: research
Abstract Despite a clear association between human papillomavirus and cervical cancer, knowledge in adolescent populations regarding the disease and methods for its detection and prevention is deficient. The aim of this study was to develop and test a new questionnaire concerning knowledge on cervical cancer. An instrument was developed and validated to measure knowledge in 226 Chilean adolescents between April and June 2011. Content validity, construct validity, and reliability analysis of the instrument were performed. The new, validated instrument, called CEC-61 (Conocimientos en Cancer Cérvicouterino-61...
Source: Women and Health - Category: Primary Care Authors: Tags: Women Health Source Type: research
Pap smears, once recommended annually to screen women for cervical cancer, have decreased in frequency in the past few years as screening and vaccinations for human papillomavirus, the virus that causes the vast majority of cervical cancer cases, have become more widespread — a trend Pittsburgh doctors say could lead medicine away from the pap smear altogether. While countries like the Netherlands and Australia have abandoned the pap smear in favor of HPV-only testing, most U.S. doctors still…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Women, especially black women, might face a greater chance of dying of cervical cancer than previously thought, according to a study published Monday in the journal Cancer. Estimates from previous studies may have been artificially low because they included women who had had hysterectomies, a procedure to remove the uterus. The new study suggests that black women are dying at a rate 77 percent higher, and white women are dying at a rate 47 percent higher, than researchers had previously thought. After adjusting for hysterectomies, cervical cancer killed 10 out of every 100,000 black women and approximately 5 out ...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Cervical cancer is preventable because of immunization with human papillomavirus (HPV) vaccine and the Papanicolaou test that facilitates early identification and treatment of precancer.1 Despite these strategies, approximately 12,900 females in the United States will be diagnosed with cervical cancer in 2016 while approximately 4,120 will die from the disease.1
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Tags: Prescription Pad Source Type: research
Objectives Cervical cancer incidence and mortality is increasing in Japanese women under age 50. Screening uptake is low and proactive recommendations for human papillomavirus vaccination have been suspended. Other cervical cancer prevention initiatives are urgently needed. We assessed whether human papillomavirus self-sampling might be an acceptable alternative to physician-led screening, particularly in women with limited experience of tampon use. We also sought to identify any practical, logistical, or safety issues in women already attending for screening, before carrying out further large-scale studies in non-responde...
Source: Journal of Medical Screening - Category: Epidemiology Authors: Tags: Original Articles Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Papanicolaou (Pap) Smear | Study | Vaccines | Wales Health | Women